Results

Total Results: 925 records

Showing results for "failure".

  1. S9 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s9.pdf
    October 01, 2007 - ORIGINAL ARTICLE Medicare Part D Data Major Changes on the Horizon Leslie M. Greenwald, PhD Background: The 3 primary administrative data sets developed by the Centers for Medicare and Medicaid services (CMS) to support the Medicare Part D program implementation represent a valuable source of data for health service…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
    June 01, 2013 - Failure to stratify or disaggregate outcome data according to the treatment Table A. … This trial was considered to have a high risk of bias, primarily due to failure to provide details … Upon local failure, patients enter into a new category centered on systemic chemotherapy.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
    April 01, 2014 - enema alone or no preparation, only two provided information on harms (1 for nausea and 1 for renal failure … patients receiving OMBP versus 1 of 89 patients receiving no preparation experienced acute renal failure … Renal failure, an outcome considered important given that many OMBP strategies involve ingestion of
  4. effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
    February 24, 2016 - issue with the statement “The higher local recurrence rate does not necessarily indicate a biological failure … By definition of more than one treatment is required, IT DOES INDICATE BIOLOGICAL FAILURE of the treatment … Furthermore, this contradicts the prior endorsement of the Definition of primary treatment failure
  5. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - However, in May 2014, Corcept halted development of mifepristone for this indication, citing a failure … potential at this time, citing three reasons: limited efficacy data for treating binge-eating disorder, failure … negative associations, resulting in limited patient engagement, reduced adherence to treatment, and failure
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-tools_research-protocol.pdf
    April 14, 2016 - in relevant populations and settings including the intensive care unit, oncology, pediatrics, heart failure
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
    July 13, 2011 - include but are not limited to nausea, diarrhea, headache, tremor, daytime sedation, decreased libido, failure
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
    March 01, 2018 - Allergen specific immunotherapy induced multi-organ failure.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
    November 01, 2012 - baseline disease severity, affected BSA, disease location, number and type of previous treatments, failure
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pain-chronic_disposition-comments.pdf
    September 01, 2011 - I believe that they attribute insurance tactics to their failure too frequently.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
    May 01, 2012 - of a psychosocial and/or pharmacological treatment to an existing treatment after treatment failure … and psychosocial interventions, as either the initial line of treatment or as the option following failure … Addition of a psychosocial and/or pharmacological treatment to an existing treatment after treatment failure … The natural history of congestive heart failure: the Framingham study.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
    January 01, 2013 - Background Iron overload increases the risk for liver disease (cirrhosis, cancer), heart attack or heart failure … Contribution of iron deficiency to anemia in chronic renal failure. … ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure … Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
    May 04, 2013 - tubes used _ Average duration of TT insertion _ Type of follow-up _ Potential causation of tube failure … "Few studies provided a power analysis so making it difficult to interpret failure to find differences … Without such information, we could not determine with confidence whether a failure to find differences … The failure to recognize that there were no comparisons between adenoidectomy and no intervention means
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
    January 01, 2019 - 1 vs. 7 Reoperation type Decompression: 4 vs. 18 Fusion: 12 vs. 45 NR Cardiac event: 3 vs. 0 Kidney failure … but sham tip received no current and remained at body temp NR Allowed after 3 months for treatment failure … reduction following the index treatment, for FJI and C-LRFA, respectively), and not counted as a treatment failure … Crossover before 12 months considered treatment failure A vs.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - treatment-related adverse events (e.g., drug side effects); does not include consequences related to the failure … include lactic acidosis, serious hypoglycemia (most often in combination with other agents) and liver failure
  16. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - those requiring ongoing daily medication use for conditions such as tuberculosis, diabetes, heart failureFailure to determine these thresholds during Phase 2 is believed to be one of the main reasons for
  17. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - those requiring ongoing daily medication use for conditions such as tuberculosis, diabetes, heart failureFailure to determine these thresholds during Phase 2 is believed to be one of the main reasons for
  18. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - track medication adherence in patients with chronic conditions such as tuberculosis, diabetes, heart failureFailure to determine these thresholds during Phase 2 is believed to be one of the main reasons for
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_disposition-comments.pdf
    June 12, 2013 - We believe this failure has prevented us from contributing meaningfully to the benefit of patients and … apparent adjustment was made to the data to account for those who received systemic therapies after failure
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - had been approved in Europe for the treatment of symptomatic anemia associated with chronic renal failure … clinical trials.34-36 Erythropoietin was first approved for the treatment of anemia in chronic kidney failure

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: